Pay in 4 interest-free payments of $6.86 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Average Results: Lose 15-20% of body weight
Retatrutide is not started at the maintenance dose
Second, oral Wegovy at the higher 25 mg dose has been approved in the US since December 2025
Glucagon increases heart rate & cardiac output/contractility while lowering pulmonary vascular resistance
The clinical program involving the triple agonist retatrutide will uniquely be utilizing a basket trial format A basket trial is a type of clinical trial that evaluates the effect of a single drug across multiple disease states that share a common feature, in this case obesity A basket design nests under a single master protocol multiple subtrials, or baskets, each with its own population, endpoints and analysis plan
US$ 29.18
US$ 22.96
US$ 26.34
US$ 22.14
